These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 34951575)

  • 1. Role of Tumor Microenvironment in Cancer Stem Cells Resistance to Radiotherapy.
    Taeb S; Ashrafizadeh M; Zarrabi A; Rezapoor S; Musa AE; Farhood B; Najafi M
    Curr Cancer Drug Targets; 2022; 22(1):18-30. PubMed ID: 34951575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Taking a Full Snapshot of Cancer Biology: Deciphering the Tumor Microenvironment for Effective Cancer Therapy in the Oncology Clinic.
    Dzobo K
    OMICS; 2020 Apr; 24(4):175-179. PubMed ID: 32176591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tumor microenvironment and radiotherapy response; a central role for cancer-associated fibroblasts.
    Ansems M; Span PN
    Clin Transl Radiat Oncol; 2020 May; 22():90-97. PubMed ID: 32337377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor microenvironment-based screening repurposes drugs targeting cancer stem cells and cancer-associated fibroblasts.
    Lee PJ; Ho CC; Ho H; Chen WJ; Lin CH; Lai YH; Juan YC; Chu WC; Lee JH; Su SF; Chen HY; Chen JJW; Chang GC; Li KC; Yang PC; Chen HW
    Theranostics; 2021; 11(19):9667-9686. PubMed ID: 34646392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic reprogramming and crosstalk of cancer-related fibroblasts and immune cells in the tumor microenvironment.
    Zhu Y; Li X; Wang L; Hong X; Yang J
    Front Endocrinol (Lausanne); 2022; 13():988295. PubMed ID: 36046791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cancer stem cells (CSCs) in cancer progression and therapy.
    Najafi M; Farhood B; Mortezaee K
    J Cell Physiol; 2019 Jun; 234(6):8381-8395. PubMed ID: 30417375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cancer-associated fibroblasts in radiotherapy: Bystanders or protagonists?
    Martinez-Zubiaurre I; Hellevik T
    Cell Commun Signal; 2023 May; 21(1):108. PubMed ID: 37170098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance.
    Khalaf K; Hana D; Chou JT; Singh C; Mackiewicz A; Kaczmarek M
    Front Immunol; 2021; 12():656364. PubMed ID: 34122412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
    Erin N; Grahovac J; Brozovic A; Efferth T
    Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The tumor microenvironment as driver of stemness and therapeutic resistance in breast cancer: New challenges and therapeutic opportunities.
    Mehraj U; Ganai RA; Macha MA; Hamid A; Zargar MA; Bhat AA; Nasser MW; Haris M; Batra SK; Alshehri B; Al-Baradie RS; Mir MA; Wani NA
    Cell Oncol (Dordr); 2021 Dec; 44(6):1209-1229. PubMed ID: 34528143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives.
    Mao X; Xu J; Wang W; Liang C; Hua J; Liu J; Zhang B; Meng Q; Yu X; Shi S
    Mol Cancer; 2021 Oct; 20(1):131. PubMed ID: 34635121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer stem cell secretome in the tumor microenvironment: a key point for an effective personalized cancer treatment.
    López de Andrés J; Griñán-Lisón C; Jiménez G; Marchal JA
    J Hematol Oncol; 2020 Oct; 13(1):136. PubMed ID: 33059744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exploring the interplay between triple-negative breast cancer stem cells and tumor microenvironment for effective therapeutic strategies.
    Zou Z; Luo T; Wang X; Wang B; Li Q
    J Cell Physiol; 2024 Aug; 239(8):e31278. PubMed ID: 38807378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cancer associated-fibroblast-derived exosomes in cancer progression.
    Li C; Teixeira AF; Zhu HJ; Ten Dijke P
    Mol Cancer; 2021 Dec; 20(1):154. PubMed ID: 34852849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Architecture of Cancer-Associated Fibroblasts in Tumor Microenvironment: Mapping Their Origins, Heterogeneity, and Role in Cancer Therapy Resistance.
    Dzobo K; Dandara C
    OMICS; 2020 Jun; 24(6):314-339. PubMed ID: 32496970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The interplay between cancer associated fibroblasts and immune cells in the context of radiation therapy.
    Piper M; Mueller AC; Karam SD
    Mol Carcinog; 2020 Jul; 59(7):754-765. PubMed ID: 32363633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunobiology of cancer-associated fibroblasts in the context of radiotherapy.
    Hellevik T; Berzaghi R; Lode K; Islam A; Martinez-Zubiaurre I
    J Transl Med; 2021 Oct; 19(1):437. PubMed ID: 34663337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies.
    Li YR; Fang Y; Lyu Z; Zhu Y; Yang L
    J Transl Med; 2023 Oct; 21(1):686. PubMed ID: 37784157
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic Relationship between Cancer-Associated Fibroblasts and Cancer Cells.
    Sazeides C; Le A
    Adv Exp Med Biol; 2018; 1063():149-165. PubMed ID: 29946782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer-associated fibroblasts and the tumor microenvironment in non-small cell lung cancer.
    Suzuki J; Tsuboi M; Ishii G
    Expert Rev Anticancer Ther; 2022 Feb; 22(2):169-182. PubMed ID: 34904919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.